...
首页> 外文期刊>Journal of biomedical materials research, Part A >Paclitaxel-loaded silk fibroin nanospheres.
【24h】

Paclitaxel-loaded silk fibroin nanospheres.

机译:紫杉醇负载的丝素蛋白纳米球。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Silk fibroin is a very promising biomedical material because of its renewability, nontoxicity, biocompatibility, and biodegradability. On the basis of a simple and mild method for the preparation of silk fibroin nanospheres with controllable size, the authors developed earlier, anti-cancer drug paclitaxel (PTX)-loaded silk fibroin nanospheres ranging from 270 to 520 nm were produced accordingly. The drug loading, encapsulation efficiency, and released property of PTX-loaded silk fibroin nanospheres are depended on the silk fibroin concentration and initial PTX-loading capacity. The maximum drug loading is about 6.9% and the release time of such a kind of nanospheres is over 9 days. The release time of PTX-loaded silk fibroin nanospheres can be as long as 2 weeks when the drug loading is about 3.0%. All these results imply that such a kind of biomacromolecule-based anti-cancer drug nanocarrier has a great potential for chemotherapy in clinical applications.
机译:丝素蛋白由于其可更新性,无毒性,生物相容性和生物降解性,是一种非常有前途的生物医学材料。在简单而温和的制备尺寸可控的丝素蛋白纳米球的基础上,作者较早地开发了相应的抗癌药物紫杉醇(PTX)负载的丝素蛋白纳米球,其制备范围为270至520 nm。载有PTX的丝素蛋白纳米球的载药量,包封效率和释放性能取决于丝素蛋白的浓度和初始PTX载量。最大载药量约为6.9%,此类纳米球的释放时间超过9天。当载药量约为3.0%时,载有PTX的丝素蛋白纳米球的释放时间可长达2周。所有这些结果表明,这种基于生物大分子的抗癌药物纳米载体在临床应用中具有巨大的化疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号